GHRS
Price
$12.44
Change
+$0.04 (+0.32%)
Updated
Jun 27 closing price
Capitalization
771.65M
52 days until earnings call
HCWB
Price
$4.50
Change
+$0.28 (+6.64%)
Updated
Jun 27 closing price
Capitalization
9.36M
Interact to see
Advertisement

GHRS vs HCWB

Header iconGHRS vs HCWB Comparison
Open Charts GHRS vs HCWBBanner chart's image
GH Research
Price$12.44
Change+$0.04 (+0.32%)
Volume$81.61K
Capitalization771.65M
HCW Biologics
Price$4.50
Change+$0.28 (+6.64%)
Volume$3.56M
Capitalization9.36M
GHRS vs HCWB Comparison Chart in %
Loading...
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCWB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GHRS vs. HCWB commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a Buy and HCWB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GHRS: $12.44 vs. HCWB: $4.50)
Brand notoriety: GHRS and HCWB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 49% vs. HCWB: 360%
Market capitalization -- GHRS: $771.65M vs. HCWB: $9.36M
GHRS [@Biotechnology] is valued at $771.65M. HCWB’s [@Biotechnology] market capitalization is $9.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 1 FA rating(s) are green whileHCWB’s FA Score has 0 green FA rating(s).

  • GHRS’s FA Score: 1 green, 4 red.
  • HCWB’s FA Score: 0 green, 5 red.
According to our system of comparison, GHRS is a better buy in the long-term than HCWB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 3 TA indicator(s) are bullish while HCWB’s TA Score has 2 bullish TA indicator(s).

  • GHRS’s TA Score: 3 bullish, 5 bearish.
  • HCWB’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, both GHRS and HCWB are a bad buy in the short-term.

Price Growth

GHRS (@Biotechnology) experienced а +1.06% price change this week, while HCWB (@Biotechnology) price change was -3.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GHRS is expected to report earnings on Aug 20, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($772M) has a higher market cap than HCWB($9.36M). GHRS YTD gains are higher at: 77.714 vs. HCWB (-74.781). HCWB has higher annual earnings (EBITDA): -21.71M vs. GHRS (-41.75M). GHRS has more cash in the bank: 291M vs. HCWB (1.11M). GHRS has less debt than HCWB: GHRS (658K) vs HCWB (13.9M). HCWB has higher revenues than GHRS: HCWB (1.45M) vs GHRS (0).
GHRSHCWBGHRS / HCWB
Capitalization772M9.36M8,251%
EBITDA-41.75M-21.71M192%
Gain YTD77.714-74.781-104%
P/E RatioN/AN/A-
Revenue01.45M-
Total Cash291M1.11M26,264%
Total Debt658K13.9M5%
TECHNICAL ANALYSIS
Technical Analysis
GHRSHCWB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
87%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HCWB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PENN18.280.02
+0.11%
PENN Entertainment
AUTL2.31N/A
N/A
Autolus Therapeutics plc
CHWY42.83-0.60
-1.38%
Chewy
AKA10.70-0.29
-2.64%
aka Brands Holding Corp
JVA4.25-0.14
-3.19%
Coffee Holding Co

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with IVVD. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then IVVD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
+0.32%
IVVD - GHRS
39%
Loosely correlated
N/A
ATAI - GHRS
38%
Loosely correlated
-2.22%
CLDI - GHRS
29%
Poorly correlated
-2.31%
MNMD - GHRS
27%
Poorly correlated
-2.82%
VTGN - GHRS
26%
Poorly correlated
-3.90%
More

HCWB and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCWB has been loosely correlated with APLM. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HCWB jumps, then APLM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCWB
1D Price
Change %
HCWB100%
+6.64%
APLM - HCWB
45%
Loosely correlated
+1.51%
GHRS - HCWB
25%
Poorly correlated
+0.32%
ACRS - HCWB
24%
Poorly correlated
N/A
GALT - HCWB
24%
Poorly correlated
-7.17%
TRAW - HCWB
23%
Poorly correlated
N/A
More